Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

Treatment with antidepressants:
what to expect from starting to stopping

Someone starting an antidepressant may experience a side effect before noticing a benefit. Nausea may occur in the first few days, whereas improvements in mood and daily activities are usually assessed over a period of weeks. This is why the first follow-up appointment is important even when it is still too early to establish how well the medicine is working.

A useful starting point is to remember how you felt before the prescription. If appetite was already reduced or sleep was very disrupted, reconstructing that baseline makes it easier to distinguish a change in depression from a possible medication effect. If a symptom makes eating, driving safely or taking treatment regularly difficult, you should contact your doctor sooner.

At the start of antidepressant treatment, it is useful to clarify:


When symptoms ease, the next decision concerns how long to continue treatment after remission. Returning to work or starting to sleep well again may be an initial improvement. Planning the end of treatment also involves considering any remaining symptoms, previous episodes and whether the dose can be reduced gradually with the prescriber.

Starting treatment and time to response

The choice of medication also depends on what was happening before the first dose. Someone who already has insomnia, has lost weight or has little sexual desire can record this at the start of treatment. At follow-up it will be easier to recognize a new effect. The doctor also needs a list of medicines and supplements, experiences with antidepressants already tried and any periods of very high energy with very little sleep but no tiredness. If you are pregnant, planning pregnancy or breastfeeding, this should be considered from the time the medicine is prescribed.

Instructions about timing and missed doses depend on the specific product prescribed. Check the patient information leaflet or ask a pharmacist. Before starting, it is also useful to know whom to call if you cannot take the medicine regularly. For example, nausea that causes you to miss several doses changes both treatment tolerability and how an apparent lack of benefit should be interpreted.

The first follow-up appointment is usually scheduled within two weeks. NICE guidelines recommend a review after approximately one week for people aged 18 to 25 or at increased risk of suicide. At this stage, sleep, agitation, safety and whether it is actually possible to continue treatment are important. In many cases it is still too early to judge how much mood will improve.

When the medication works, some benefit usually begins to appear within about four weeks. In everyday life, this may mean being able to read or prepare lunch again, even while still feeling depressed. If symptoms remain unchanged after several weeks at the prescribed dose, the doctor may reassess the diagnosis, treatment duration, doses actually taken and subsequent options. Marked deterioration, however, requires earlier contact.

Adverse effects:
nausea, weight and sexual function

Nausea, diarrhoea or constipation, drowsiness and difficulty sleeping may occur with some antidepressants. Nausea, for example, is a common effect of sertraline. It may subside over the following days. Whether to wait or review treatment also depends on the consequences of the symptom. Mild nausea that passes after breakfast differs from feeling unwell for days to the point of being unable to eat or take the medication. If drowsiness impairs alertness, avoid driving and contact the prescriber without waiting for the next appointment.

Weight should be interpreted in light of what was happening before treatment. Someone who lost weight during the episode may begin eating again as their appetite returns. In another person, hunger and weight may increase during treatment even after mood has stabilized. Increased appetite is, for example, a known effect of mirtazapine. Reporting how appetite and weight have changed over the weeks helps the doctor assess the roles of depression, medication and other possible causes. A single reading on the scales says little about the pattern.

Sexual function can also change in different ways. Loss of sexual desire may already occur during depression. Difficulty with arousal or orgasm appearing after medication is started, perhaps just as desire is returning, is a separate clinical observation. Someone experiencing this may be tempted to skip a tablet on days when they expect to have sex. Discussing it with the doctor is preferable, because interruptions can cause withdrawal symptoms and make treatment harder to assess. A solution can be sought that takes into account the benefit achieved and how much the difficulty affects the couple’s relationship.

Some changes warrant prompt contact with the doctor, particularly new severe agitation or a sudden shift to needing very little sleep, with unusually high energy and impulsivity. If suicidal thoughts appear or intensify, seek a same-day assessment. If you intend to act soon, have already done something dangerous or cannot stay safe, call 112 or 118 immediately and ask someone to stay with you.

How long to continue treatment after remission

Several weeks may pass between the point when someone first notices feeling better and the point when symptoms have largely resolved. The initial improvement is called a response. Remission means a more complete recovery. For example, someone may have returned to work but still wake very early, experience thoughts of guilt and have little interest in anything outside the office. These symptoms should be reported even when family members and colleagues mainly notice the improvement.

For many adults, continuing the antidepressant for at least six months after remission is recommended to reduce the risk of depression returning. If the first tablet was taken in January and recovery became established in the spring, the spring is the reference point for this stage of treatment. At follow-up it is useful to establish how long the improvement has also been sustained in ordinary activities.

After multiple episodes, a severe episode or an incomplete recovery, it may be appropriate to continue for longer. The decision is reviewed in light of personal history, adverse effects and preferences. If you mainly want to stop because of drowsiness or a sexual problem, explain that reason. The doctor can then weigh both the benefits of continuing to prevent relapse and ways of reducing the troublesome effect.

Gradual discontinuation and relapse risk

Discontinuation should be planned with the prescriber. The plan specifies how to move from one dose to the next, when to check symptoms and whom to contact if a reduction is difficult. The time required depends on the drug, dose, treatment duration and any previous attempts. For some people weeks are sufficient; others need months, with smaller reductions towards the end. It is worth clarifying how to obtain the prescribed doses with the available formulation.

In the days following a dose reduction, dizziness, nausea, vivid dreams, irritability or sensations resembling small electric shocks may occur. If symptoms are intense or do not subside, tell the doctor before proceeding to the next step. The date of the dose change, onset of symptoms and their course are more useful than a general impression. Alternating days with and without a tablet on your own initiative can cause medication levels to fluctuate.

A depressive relapse often involves the gradual return of familiar difficulties, whereas withdrawal symptoms may begin sooner and include new physical symptoms. There is overlap, and timing varies by medication. If distress returns during dose reduction, you do not have to resolve the uncertainty yourself before seeking reassessment. Severe deterioration or an immediate danger requires care regardless of the cause.

Frequently asked questions about antidepressant treatment

I do not feel better after ten days. Does that mean the medication is not working?
Ten days may be too soon to judge its benefits. At the first follow-up, describe how you are feeling and any side effects. Contact your clinician earlier if you deteriorate markedly, feel very agitated or develop suicidal thoughts.

Are the six months of treatment counted from the first tablet?
Usually the reference point is remission, when symptoms have largely resolved. Ask your doctor how to identify this in your case and when treatment duration will be reviewed.

Can I take a tablet every other day to stop treatment?
Only follow the schedule agreed with your prescriber. Skipping days on your own can cause medication levels to fluctuate and trigger symptoms. The taper is tailored to the medicine you are taking and your response.

References
  1. National Institute for Health and Care Excellence. Depression in adults: treatment and management. NICE guideline NG222. 2022.
  2. National Institute for Health and Care Excellence. Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults. NICE guideline NG215. 2022.
  3. Royal College of Psychiatrists. Stopping antidepressants. London: Royal College of Psychiatrists, 2024.
  4. Istituto Superiore di Sanità. Antidepressivi. ISSalute. Accessed November 2, 2026.
  5. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018;391(10128):1357-1366. doi:10.1016/S0140-6736(17)32802-7.
  6. Lewis G, Marston L, Duffy L, et al. Maintenance or Discontinuation of Antidepressants in Primary Care. New England Journal of Medicine. 2021;385(14):1257-1267. doi:10.1056/NEJMoa2106356.
  7. Henssler J, Schmidt Y, Schmidt U, et al. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. The Lancet Psychiatry. 2024;11(7):526-535. doi:10.1016/S2215-0366(24)00133-0.
  8. Petimar J, Young JG, Yu H, et al. Medication-Induced Weight Change Across Common Antidepressant Treatments: A Target Trial Emulation Study. Annals of Internal Medicine. 2024;177(8):993-1003. doi:10.7326/M23-2742.
  9. Serretti A, Chiesa A. Treatment-Emergent Sexual Dysfunction Related to Antidepressants: A Meta-Analysis. Journal of Clinical Psychopharmacology. 2009;29(3):259-266. doi:10.1097/JCP.0b013e3181a5233f.
  10. Park LT, Zarate CA Jr. Depression in the Primary Care Setting. New England Journal of Medicine. 2019;380(6):559-568. doi:10.1056/NEJMcp1712493.
  11. National Health Service. Sertraline. NHS. Accessed November 2, 2026.
  12. National Health Service. Mirtazapine. NHS. Accessed November 2, 2026.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.